2020 Revenues ($USD) : $2,702,140,673
2020 Revenues (foreign currencies) : DKK 17,672,000,000
2020 R&D spend : $694,954,128
2020 Number of Employees : 5,717
Fiscal Year End : 12/31/2020
Key People : Deborah Dunshire, president and CEO

The Danish pharmaceutical company sets itself apart when it comes to specialization. Lundbeck is one of the only pharma companies globally with an exclusive focus on brain diseases, including depression, anxiety, bipolar disorder, epilepsy, psychosis, Alzheimer's disease, Parkinson's disease and migraine. Part of the reason that Lundbeck can continue with its specialization is its ownership structure: The Lundbeck Foundation is the company's majority owner. –CN